Skip to content
HowShorted

BIO KEY INTERNATIONAL INC short interest in 2022

In 2022, BIO KEY INTERNATIONAL INC's disclosed short interest ran from 1.04% of shares outstanding on 14 Jan 2022 to 0.61% on 30 Dec 2022, a change of -0.43 percentage points. The year's high was 1.65% on 29 Apr 2022 and its low 0.61% on 30 Dec 2022, averaging 0.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.92 days on 14 Oct 2022. Full history: BIO KEY INTERNATIONAL INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for BIO KEY INTERNATIONAL INC in 2022

2022 in figures

Start of year
1.04% (14 Jan 2022)
End of year
0.61% (30 Dec 2022)
Change
-0.43 pp
High
1.65% (29 Apr 2022)
Low
0.61% (30 Dec 2022)
Average
0.97%
Highest days to cover
15.92 (14 Oct 2022)
SEC filings marked
8

Every report in 2022

BIO KEY INTERNATIONAL INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20221.04%2.39
31 Jan 20221.43%3.65
15 Feb 20221.14%4.02
28 Feb 20221.06%1.27
15 Mar 20220.89%1.00
31 Mar 20221.12%1.00results (8-K)
14 Apr 20220.74%2.7610-K filed
29 Apr 20221.65%5.55
13 May 20221.06%3.46
31 May 20220.92%4.31results (8-K), 10-Q filed
15 Jun 20220.75%3.37
30 Jun 20220.88%8.22
15 Jul 20220.78%10.43
29 Jul 20220.83%6.25
15 Aug 20220.87%2.77results (8-K)
31 Aug 20221.04%8.2910-Q filed
15 Sep 20221.06%6.06
30 Sep 20221.03%9.75
14 Oct 20220.93%15.92
31 Oct 20220.82%10.38
15 Nov 20220.90%3.1210-Q filed, results (8-K)
30 Nov 20220.82%4.07
15 Dec 20220.80%4.12
30 Dec 20220.61%1.09

See also: BIO KEY INTERNATIONAL INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.